Zevra therapeutics to report first quarter 2023 results on may 15, 2023

Celebration, fla., may 09, 2023 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company, formerly kempharm, inc.), a rare disease therapeutics company, has announced that it will host a conference call and live audio webcast on monday, may 15, 2023, at 4:30 p.m. et, to review its corporate and financial results for the first quarter of 2023.

ZVRA Ratings Summary

ZVRA Quant Ranking